Proteomic profiling of lymphocytes in autoimmunity, inflammation and cancer

Table 1 Categories of study design and techniques in lymphocyte proteomics

Ref.	Disease/Activity	Total identified proteins	Samples	Country	Proteomic methods
10	IL-12 regulated CD4+ T cells differentiation	42	Blood	Finland	2-DE
10	IL-12 regulated CD4+ T cells differentiation	42	Blood	Finland	MS
13	T cell proliferation	17	Blood	Hong Kong, China	2-DE
13	T cell proliferation	17	Blood	Hong Kong, China	MALDI-TOF MS
23	Mucosal tolerance	11	Lymph node	Netherlands	2D-PAGE
23	Mucosal tolerance	11	Lymph node	Netherlands	MALDI-TOF MS
27	T-cell vaccination (TCV)	11	Activated mouse ovalbumin-specific T cells	P. R. China	2-DE
27	T-cell vaccination (TCV)	11	Activated mouse ovalbumin-specific T cells	P. R. China	Q-TOF MS
28	Vogt-Koyanagi-Harada (VKH) syndrome	30	Blood	United States of America	LC-MS/MS
29	Rheumatic heart disease (RHD)	3	Blood	Brazil	2-DE
29	Rheumatic heart disease (RHD)	3	Cardiac tissue	Brazil	MALDI-TOF MS
32	Tyrosine phosphorylation	3	Primary human lymphocyte	United States of America	2D-PAGE
37	Immunosuppression	10	E6-1 cell line	Spain	2D-PAGE
38	Colitis	26	Lymph node	P. R. China	2D-PAGE
38	Colitis	26	Lymph node	P. R. China	MS
45	Pseudomonas aeruginosa sepsis	11	Blood	P. R. China	2-DE
45	Pseudomonas aeruginosa sepsis	11	Blood	P. R. China	MALDI-TOF MS
46	DNA repair capacity (cell-cycle checkpoint-related protein)	8	Blood	United States of America	Reverse-phase protein lysate microarray assay
49	Asthma	25	Blood	South Korea	2D-PAGE
49	Asthma	25	Blood	South Korea	MALDI-TOF MS
50	Asthma	13	Blood	Taiwan, China	2D-PAGE
50	Asthma	13	Blood	Taiwan, China	LC/MS

ISSN: 1479-5876